Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001770121-25-000010
Filing Date
2025-08-11
Accepted
2025-08-11 16:10:42
Documents
80
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sana-20250630.htm   iXBRL 10-Q 3182144
2 EX-10.1 sana-ex10_1.htm EX-10.1 32877
3 EX-31.1 sana-ex31_1.htm EX-31.1 18037
4 EX-32.1 sana-ex32_1.htm EX-32.1 9839
  Complete submission text file 0001770121-25-000010.txt   11133417

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sana-20250630.xsd EX-101.SCH 1363698
82 EXTRACTED XBRL INSTANCE DOCUMENT sana-20250630_htm.xml XML 1995577
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39941 | Film No.: 251202095
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)